Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
- 30 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 52 (1), 9-22
- https://doi.org/10.1007/s40262-012-0020-y
Abstract
Therapeutic drug monitoring (TDM) aims to optimize treatments by individualizing dosage regimens based on the measurement of blood concentrations. Dosage individualization to maintain concentrations within a target range requires pharmacokinetic and clinical capabilities. Bayesian calculations currently represent the gold standard TDM approach but require computation assistance. In recent decades computer programs have been developed to assist clinicians in this assignment. The aim of this survey was to assess and compare computer tools designed to support TDM clinical activities. The literature and the Internet were searched to identify software. All programs were tested on personal computers. Each program was scored against a standardized grid covering pharmacokinetic relevance, user friendliness, computing aspects, interfacing and storage. A weighting factor was applied to each criterion of the grid to account for its relative importance. To assess the robustness of the software, six representative clinical vignettes were processed through each of them. Altogether, 12 software tools were identified, tested and ranked, representing a comprehensive review of the available software. Numbers of drugs handled by the software vary widely (from two to 180), and eight programs offer users the possibility of adding new drug models based on population pharmacokinetic analyses. Bayesian computation to predict dosage adaptation from blood concentration (a posteriori adjustment) is performed by ten tools, while nine are also able to propose a priori dosage regimens, based only on individual patient covariates such as age, sex and bodyweight. Among those applying Bayesian calculation, MM-USC*PACK© uses the non-parametric approach. The top two programs emerging from this benchmark were MwPharm© and TCIWorks. Most other programs evaluated had good potential while being less sophisticated or less user friendly. Programs vary in complexity and might not fit all healthcare settings. Each software tool must therefore be regarded with respect to the individual needs of hospitals or clinicians. Programs should be easy and fast for routine activities, including for non-experienced users. Computer-assisted TDM is gaining growing interest and should further improve, especially in terms of information system interfacing, user friendliness, data storage capability and report generation.Keywords
This publication has 46 references indexed in Scilit:
- An agenda for UK clinical pharmacology: Monitoring drug therapyBritish Journal of Clinical Pharmacology, 2012
- Therapeutic Drug Monitoring of ImatinibClinical Pharmacokinetics, 2012
- Computerized clinical decision support systems for therapeutic drug monitoring and dosing: A decision-maker-researcher partnership systematic reviewImplementation Science, 2011
- Pharmacogenomic biomarkers: new tools in current and future drug therapyTrends in Pharmacological Sciences, 2011
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical SignificanceClinical Pharmacokinetics, 2009
- Practical Therapeutic Drug Management in HIV‐Infected Patients: Use of Population Pharmacokinetic Models Supplemented by Individualized Bayesian Dose OptimizationThe Journal of Clinical Pharmacology, 2008
- Parametric and Nonparametric Population MethodsClinical Pharmacokinetics, 2006
- Food-Drug InteractionsDrugs, 2002
- Model-Based, Goal-Oriented, Individualised Drug TherapyClinical Pharmacokinetics, 1998
- Computers in PharmacokineticsClinical Pharmacokinetics, 1993